Clinical Trial Update: Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety and tolerability of flexible doses of oral ziprasidone in children and adolescents with Bipolar I Disorder (manic or mixed) wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: WITHDRAWN